SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-017163
Filing Date
2021-07-20
Accepted
2021-07-19 18:42:03
Documents
14
Period of Report
2021-07-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20210715_8k.htm   iXBRL 8-K 29468
2 EXHIBIT 16.1 ex_264392.htm EX-16.1 2844
  Complete submission text file 0001437749-21-017163.txt   170275

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20210716.xsd EX-101.SCH 3701
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20210716_def.xml EX-101.DEF 11975
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20210716_lab.xml EX-101.LAB 16020
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20210716_pre.xml EX-101.PRE 12184
7 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20210715_8k_htm.xml XML 2649
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 211098930
SIC: 2836 Biological Products, (No Diagnostic Substances)